NO20020664L - Streptomyces Avermitilis gen som bestemmer forholdet B2:B1 avermectiner - Google Patents

Streptomyces Avermitilis gen som bestemmer forholdet B2:B1 avermectiner

Info

Publication number
NO20020664L
NO20020664L NO20020664A NO20020664A NO20020664L NO 20020664 L NO20020664 L NO 20020664L NO 20020664 A NO20020664 A NO 20020664A NO 20020664 A NO20020664 A NO 20020664A NO 20020664 L NO20020664 L NO 20020664L
Authority
NO
Norway
Prior art keywords
avermectins
determines
ratio
streptomyces avermitilis
avermitilis gene
Prior art date
Application number
NO20020664A
Other languages
English (en)
Norwegian (no)
Other versions
NO20020664D0 (no
Inventor
Yan Chen
Claes Gustafsson
Anke Krebber
Jeremy Stephen Minshull
Sun Ai Raillard
Kim Jonelle Stutzman-Engwall
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of NO20020664D0 publication Critical patent/NO20020664D0/no
Publication of NO20020664L publication Critical patent/NO20020664L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/181—Heterocyclic compounds containing oxygen atoms as the only ring heteroatoms in the condensed system, e.g. Salinomycin, Septamycin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides
    • C12P19/60—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • C12P19/62—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin
    • C12P19/623—Avermectin; Milbemycin; Ivermectin; C-076

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO20020664A 1999-08-12 2002-02-11 Streptomyces Avermitilis gen som bestemmer forholdet B2:B1 avermectiner NO20020664L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14864599P 1999-08-12 1999-08-12
PCT/IB2000/001017 WO2001012821A1 (en) 1999-08-12 2000-07-24 Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins

Publications (2)

Publication Number Publication Date
NO20020664D0 NO20020664D0 (no) 2002-02-11
NO20020664L true NO20020664L (no) 2002-02-11

Family

ID=22526696

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20020664A NO20020664L (no) 1999-08-12 2002-02-11 Streptomyces Avermitilis gen som bestemmer forholdet B2:B1 avermectiner

Country Status (39)

Country Link
US (3) US6632673B1 (cs)
EP (1) EP1200606B1 (cs)
JP (1) JP3884651B2 (cs)
KR (1) KR100489856B1 (cs)
CN (1) CN1186446C (cs)
AP (1) AP2002002418A0 (cs)
AR (1) AR022646A1 (cs)
AT (1) ATE341632T1 (cs)
AU (1) AU778837B2 (cs)
BG (1) BG65902B1 (cs)
BR (1) BRPI0013119B8 (cs)
CA (1) CA2380872C (cs)
CO (1) CO5290295A1 (cs)
CY (1) CY1105778T1 (cs)
CZ (1) CZ304402B6 (cs)
DE (1) DE60031126T2 (cs)
DK (1) DK1200606T3 (cs)
EA (1) EA200200056A1 (cs)
ES (1) ES2272299T3 (cs)
GT (1) GT200000136A (cs)
HK (1) HK1046710B (cs)
HR (1) HRP20020130A2 (cs)
HU (1) HU230600B1 (cs)
IL (2) IL147563A0 (cs)
IS (1) IS6250A (cs)
MA (1) MA26813A1 (cs)
MX (1) MXPA02001513A (cs)
NO (1) NO20020664L (cs)
NZ (1) NZ516517A (cs)
OA (1) OA11998A (cs)
PA (1) PA8499501A1 (cs)
PE (1) PE20010690A1 (cs)
PL (1) PL203818B1 (cs)
PT (1) PT1200606E (cs)
SK (1) SK288086B6 (cs)
TN (1) TNSN00171A1 (cs)
UY (1) UY26286A1 (cs)
WO (1) WO2001012821A1 (cs)
ZA (1) ZA200201072B (cs)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60031126T2 (de) * 1999-08-12 2007-02-08 Pfizer Products Inc., Groton Streptomyces avermitilis gen zum regulieren des verhältnisses der b2:b1 avermectinen
CN1630712B (zh) * 2002-02-12 2011-09-28 辉瑞产品公司 指导b2:b1除虫菌素比例的除虫链霉菌基因
US7943160B2 (en) * 2002-05-09 2011-05-17 Scimetrics Limited Corp. Pest control methods
US9493744B2 (en) * 2012-06-20 2016-11-15 Genentech, Inc. Methods for viral inactivation and other adventitious agents
KR102657859B1 (ko) 2021-04-07 2024-04-16 윤재식 일체형 내화 소켓

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5238848A (en) 1987-01-23 1993-08-24 Pfizer Inc Cultures for production of avermectins
US5234831A (en) 1987-01-23 1993-08-10 Pfizer Inc Cultures for production of B avermectins
US5525506A (en) 1987-01-23 1996-06-11 Pfizer Inc. Process for production of avermectins and cultures therefor
IN167980B (cs) * 1987-01-23 1991-01-19 Pfizer
US5240850A (en) 1987-10-23 1993-08-31 Pfizer Inc. Cultures for production of avermectin aglycones
EP0313297B1 (en) 1987-10-23 1993-05-19 Pfizer Inc. Process for production of avermectin aglycones and cultures therefor
US5252474A (en) 1989-03-31 1993-10-12 Merck & Co., Inc. Cloning genes from Streptomyces avermitilis for avermectin biosynthesis and the methods for their use
EP0391594B1 (en) 1989-03-31 1995-10-18 Merck & Co. Inc. Cloning genes from streptomyces avermitilis for avermectin biosynthesis and the methods for their use
WO1995004150A1 (en) 1993-07-30 1995-02-09 Pfizer Inc. Genes encoding branched-chain alpha-ketoacid dehydrogenase complex from streptomyces avermitilis
FI942725A7 (fi) 1993-12-16 1995-06-17 Pfizer Haaraketjuista alfaketohappodenydrogenaasikompleksia koodaavia geenejä Streptomyces avermitiliksesta
US6335160B1 (en) 1995-02-17 2002-01-01 Maxygen, Inc. Methods and compositions for polypeptide engineering
US6117679A (en) 1994-02-17 2000-09-12 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US5837458A (en) 1994-02-17 1998-11-17 Maxygen, Inc. Methods and compositions for cellular and metabolic engineering
US5605793A (en) 1994-02-17 1997-02-25 Affymax Technologies N.V. Methods for in vitro recombination
US6096548A (en) 1996-03-25 2000-08-01 Maxygen, Inc. Method for directing evolution of a virus
EP0964922A4 (en) 1996-09-27 2000-10-25 Maxygen Inc METHOD FOR OPTIMIZING GENE THERAPY BY REPEATING SEQUENCE MIXING AND SELECTION
EP1717322B1 (en) 1997-01-17 2012-07-18 Codexis Mayflower Holdings, LLC Evolution of whole cells and organisms by recursive sequence recombination
AU1449499A (en) 1997-10-31 1999-05-24 Maxygen, Incorporated Modification of virus tropism and host range by viral genome shuffling
NZ518657A (en) * 1998-02-13 2003-10-31 Pfizer Prod Inc Streptomyces hygroscopicus directing the ratio of B2:B1 avermectins
US6248579B1 (en) * 1998-02-13 2001-06-19 Pfizer Inc Streptomyces avermitilis gene directing the ratio of B2:B1 avermectins
DE60031126T2 (de) * 1999-08-12 2007-02-08 Pfizer Products Inc., Groton Streptomyces avermitilis gen zum regulieren des verhältnisses der b2:b1 avermectinen

Also Published As

Publication number Publication date
PA8499501A1 (es) 2001-12-14
PE20010690A1 (es) 2001-07-06
NZ516517A (en) 2003-10-31
HUP0202487A2 (en) 2002-10-28
JP3884651B2 (ja) 2007-02-21
KR20020029379A (ko) 2002-04-18
OA11998A (en) 2006-04-18
ES2272299T3 (es) 2007-05-01
CA2380872C (en) 2007-11-27
CO5290295A1 (es) 2003-06-27
SK1392002A3 (en) 2002-12-03
UY26286A1 (es) 2001-03-16
BR0013119B1 (pt) 2014-02-25
CN1186446C (zh) 2005-01-26
HRP20020130A2 (en) 2003-06-30
US6632673B1 (en) 2003-10-14
ATE341632T1 (de) 2006-10-15
BRPI0013119B8 (pt) 2021-05-25
CN1373809A (zh) 2002-10-09
EP1200606B1 (en) 2006-10-04
GT200000136A (es) 2002-02-01
JP2003507017A (ja) 2003-02-25
KR100489856B1 (ko) 2005-05-17
CA2380872A1 (en) 2001-02-22
PL203818B1 (pl) 2009-11-30
HU230600B1 (hu) 2017-02-28
DE60031126T2 (de) 2007-02-08
PL353874A1 (en) 2003-12-01
HK1046710A1 (en) 2003-01-24
DK1200606T3 (da) 2007-01-08
CZ2002296A3 (cs) 2002-08-14
EP1200606A1 (en) 2002-05-02
CY1105778T1 (el) 2011-02-02
AU5838600A (en) 2001-03-13
SK288086B6 (sk) 2013-06-03
TNSN00171A1 (fr) 2005-11-10
AR022646A1 (es) 2002-09-04
DE60031126D1 (de) 2006-11-16
PT1200606E (pt) 2006-12-29
MXPA02001513A (es) 2002-07-02
HK1046710B (zh) 2005-05-13
MA26813A1 (fr) 2004-12-20
IS6250A (is) 2002-01-25
NO20020664D0 (no) 2002-02-11
CZ304402B6 (cs) 2014-04-16
ZA200201072B (en) 2003-04-30
AP2002002418A0 (en) 2002-03-31
IL147563A0 (en) 2002-08-14
US20030232415A1 (en) 2003-12-18
EA200200056A1 (ru) 2002-06-27
HUP0202487A3 (en) 2004-07-28
BG65902B1 (bg) 2010-04-30
US20040009560A1 (en) 2004-01-15
IL147563A (en) 2009-06-15
WO2001012821A1 (en) 2001-02-22
BG106479A (bg) 2002-10-31
AU778837B2 (en) 2004-12-23
BR0013119A (pt) 2002-04-23
US7858340B2 (en) 2010-12-28

Similar Documents

Publication Publication Date Title
AU2002224436A1 (en) Partition system with elevated raceway
MXPA03001775A (es) Derivados de nucleosidos.
AU5515901A (en) Gamma-phosphoester nucleoside triphosphates
AU2002363246A1 (en) Game with multiple chambers
AU2001272719A1 (en) Macrolide antibiotics
ZA200403684B (en) Macrolides.
AU2001278694A1 (en) Avermectin derivatives
AU2002224409A1 (en) Partition system with worktools
AU2002330717A1 (en) Monosaccharide derivatives
AU2001241910A1 (en) Distributed least choice first arbiter
NO20020665D0 (no) Streptomyces Avermitilis gen som bestemmer forholdet til B2:B1 avermectiner
ZA995872B (en) Streptomyces avermitilis regulatory genes for increased avermectin production.
NO20020664D0 (no) Streptomyces Avermitilis gen som bestemmer forholdet B2:B1 avermectiner
AU2001275898A1 (en) Avermectin pesticide with an organosilicone surfactant
ZA991138B (en) Streptomyces avermitilis gene directing the ratio of B2: B1 avermectins.
AU5789001A (en) Macrolide antiinfective agents
AU2002230386A1 (en) Sixteen-membered macrolide compounds
ZA200405345B (en) Streptomyces avermitilis gene directing the ratio of B2:B1 avermectins.
AU2002317415A1 (en) Azalide antibiotic compositions
DK1200605T3 (da) Streptomyces avermitilis gen, der dirigerer forholdet imellem B2:B1 avermectiner
AU2003285599A1 (en) Novel semisynthetic macrolide antibiotics of the azalide series
AU2690500A (en) Avermectin aglycon synthase genes
HK1071531A (en) Game with multiple chambers
AU2002346601A1 (en) Novel 11-o-substituted ketolide derivatives

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application